This inventor holds 1 USPTO granted patent and 11 published patent applications and 1 EPO patent. Top assignees: Dana-Farber-Cancer Institute Inc., Harvard College. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025
Title: Innovations in Cancer Diagnostics by Zachary D. Smith
Introduction
Zachary D. Smith is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of cancer diagnostics, particularly through his innovative methods for quantifying DNA methylation. His work aims to enhance the screening, diagnosis, and monitoring of cancer.
Latest Patents
Zachary D. Smith holds a patent for "Universal early cancer diagnostics - Methods for quantifying DNA methylation that may be utilized for screening for diseases (e.g., cancer), diagnosing diseases (e.g., cancer type), monitoring progression of a disease, and monitoring response to a therapeutic treatment." This patent represents a crucial advancement in the early detection and management of cancer.
Career Highlights
Throughout his career, Zachary has worked with prestigious institutions such as Harvard College and Dana-Farber Cancer Institute Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field of cancer research.
Collaborations
Zachary has collaborated with notable colleagues, including Alexander Meissner and Franziska Michor. These partnerships have further enriched his research and contributed to the advancement of cancer diagnostics.
Conclusion
Zachary D. Smith's innovative work in cancer diagnostics exemplifies the impact of research and invention in the medical field. His contributions are paving the way for improved cancer detection and treatment strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile